These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9076951)

  • 1. Iodine released from the wound dressing Iodosorb modulates the secretion of cytokines by human macrophages responding to bacterial lipopolysaccharide.
    Moore K; Thomas A; Harding KG
    Int J Biochem Cell Biol; 1997 Jan; 29(1):163-71. PubMed ID: 9076951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodosorb compared to standard treatment in chronic venous leg ulcers--a multicenter study.
    Hillström L
    Acta Chir Scand Suppl; 1988; 544():53-6. PubMed ID: 3051826
    [No Abstract]   [Full Text] [Related]  

  • 3. Cadexomer as well as cadexomer iodine induces the production of proinflammatory cytokines and vascular endothelial growth factor by human macrophages.
    Ohtani T; Mizuashi M; Ito Y; Aiba S
    Exp Dermatol; 2007 Apr; 16(4):318-23. PubMed ID: 17359338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cadexomer iodine (Iodosorb) compared with dextranomer (Debrisan) in the treatment of chronic leg ulcers.
    Tarvainen K
    Acta Chir Scand Suppl; 1988; 544():57-9. PubMed ID: 2459870
    [No Abstract]   [Full Text] [Related]  

  • 5. Iodoflex and Iodosorb in the treatment of venous leg ulcers.
    Bianchi J
    Br J Nurs; 2001 Mar 8-21; 10(5):342-6. PubMed ID: 12170678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cadexomer iodine paste in the treatment of venous leg ulcers compared with hydrocolloid dressing and paraffin gauze dressing. Cadexomer Iodine Study Group.
    Hansson C
    Int J Dermatol; 1998 May; 37(5):390-6. PubMed ID: 9620490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of Iodosorb in chronic venous ulcers.
    Shuttleworth GJ; Mayho GV
    Br Med J (Clin Res Ed); 1985 Aug; 291(6495):605-6. PubMed ID: 3929895
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled trial of Iodosorb in chronic venous ulcers.
    Ormiston MC; Seymour MT; Venn GE; Cohen RI; Fox JA
    Br Med J (Clin Res Ed); 1985 Aug; 291(6491):308-10. PubMed ID: 3926169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of macrophage phenotype by soluble product(s) released from neutrophils.
    Daley JM; Reichner JS; Mahoney EJ; Manfield L; Henry WL; Mastrofrancesco B; Albina JE
    J Immunol; 2005 Feb; 174(4):2265-72. PubMed ID: 15699161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of venous leg ulcers with cadexomer iodine with particular reference to iodine sensitivity.
    Floyer C; Wilkinson JD
    Acta Chir Scand Suppl; 1988; 544():60-1. PubMed ID: 2972149
    [No Abstract]   [Full Text] [Related]  

  • 11. A combative healer with no ill-effect. Iodosorb in the treatment of infected wounds.
    Johnson A
    Prof Nurse; 1991 Oct; 7(1):60, 62, 64. PubMed ID: 1946486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor modulates lipopolysaccharide (LPS)-binding and LPS-response of human macrophages: inverse regulation of tumour necrosis factor-alpha and interleukin-10.
    Kreutz M; Hennemann B; Ackermann U; Grage-Griebenow E; Krause SW; Andreesen R
    Immunology; 1999 Dec; 98(4):491-6. PubMed ID: 10594679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages.
    Chen HG; Xie KL; Han HZ; Wang WN; Liu DQ; Wang GL; Yu YH
    Int J Surg; 2013; 11(10):1060-6. PubMed ID: 24148794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shift of homeostasis from parenchymal regeneration to fibroblast proliferation induced by lipopolysaccharide-activated macrophages in gastric mucosal healing in vitro.
    Wu WK; Law PT; Wong HP; Lam EK; Tai EK; Shin VY; Cho CH
    Wound Repair Regen; 2007; 15(2):221-6. PubMed ID: 17352754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of Iodosorb in chronic venous ulcers.
    Moss C; Taylor A; Shuster S
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):902. PubMed ID: 3931763
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines.
    Refai AK; Textor M; Brunette DM; Waterfield JD
    J Biomed Mater Res A; 2004 Aug; 70(2):194-205. PubMed ID: 15227664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of anti-inflammatory macrophages for implants and regenerative medicine using self-standing release systems with a phenotype-fixing cytokine cocktail formulation.
    Riabov V; Salazar F; Htwe SS; Gudima A; Schmuttermaier C; Barthes J; Knopf-Marques H; Klüter H; Ghaemmaghami AM; Vrana NE; Kzhyshkowska J
    Acta Biomater; 2017 Apr; 53():389-398. PubMed ID: 28159717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized-controlled trial comparing cadexomer iodine and nanocrystalline silver on the healing of leg ulcers.
    Miller CN; Newall N; Kapp SE; Lewin G; Karimi L; Carville K; Gliddon T; Santamaria NM
    Wound Repair Regen; 2010; 18(4):359-67. PubMed ID: 20636550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages.
    Thorley AJ; Ford PA; Giembycz MA; Goldstraw P; Young A; Tetley TD
    J Immunol; 2007 Jan; 178(1):463-73. PubMed ID: 17182585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, regulation, and production of tumor necrosis factor-alpha in mouse testicular interstitial macrophages in vitro.
    Xiong Y; Hales DB
    Endocrinology; 1993 Dec; 133(6):2568-73. PubMed ID: 8243279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.